Fanny Frejborg

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Circulating Tumor Cells

Hyaluronic Acid

Herpes Simplex Virus

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jussi Palomäki, Kiira Kalke, Julius Orpana, Liisa M Lund, Fanny Frejborg, Henrik Paavilainen, Hannu Järveläinen, Veijo Hukkanen
Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy. Microorganisms 11 (11) (2023)
Tuomas Lasanen, Fanny Frejborg, Liisa M Lund, Marie C Nyman, Julius Orpana, Huda Habib, Salla Alaollitervo, Alesia A Levanova, Minna M Poranen, Veijo Hukkanen, Kiira Kalke
Single therapeutic dose of an antiviral UL29 siRNA swarm diminishes symptoms and viral load of mice infected intranasally with HSV-1. Smart medicine 2 (2) (2023)
Tuomas Lasanen, Fanny Frejborg, Liisa M Lund, Marie C Nyman, Julius Orpana, Huda Habib, Salla Alaollitervo, Alesia A Levanova, Minna M Poranen, Veijo Hukkanen, Kiira Kalke
Single therapeutic dose of an antiviral UL29 siRNA swarm diminishes symptoms and viral load of mice infected intranasally with HSV-1. Smart medicine 2 (2) (2023)
Fanny Frejborg, Kiira Kalke, Veijo Hukkanen
Current landscape in antiviral drug development against herpes simplex virus infections. Smart medicine 1 (1) (2022)
Fanny Frejborg, Kiira Kalke, Veijo Hukkanen
Current landscape in antiviral drug development against herpes simplex virus infections. Smart medicine 1 (1) (2022)
Kiira Kalke, Julius Orpana, Tuomas Lasanen, Olaya Esparta, Liisa M Lund, Fanny Frejborg, Tytti Vuorinen, Henrik Paavilainen, Veijo Hukkanen
The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1. Viruses 14 (6) (2022)